The Clinical Role of Intravenous Glutamine in Trauma Patients Receiving Enteral Nutrition (GLINT)
|ClinicalTrials.gov Identifier: NCT01240291|
Recruitment Status : Unknown
Verified May 2012 by Ruqaiya Al-Balushi, Royal Brisbane and Women's Hospital.
Recruitment status was: Recruiting
First Posted : November 15, 2010
Last Update Posted : May 24, 2012
Royal Brisbane and Women's Hospital
Information provided by (Responsible Party):
Ruqaiya Al-Balushi, Royal Brisbane and Women's Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||June 2013|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Al Balushi RM, Paratz JD, Cohen J, Banks M, Dulhunty J, Roberts JA, Lipman J. Effect of intravenous GLutamine supplementation IN Trauma patients receiving enteral nutrition study protocol (GLINT Study): a prospective, blinded, randomised, placebo-controlled clinical trial. BMJ Open. 2011 Nov 14;1(2):e000334. doi: 10.1136/bmjopen-2011-000334. Print 2011.